Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ODC1 | P11926 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL6422627 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL30230201 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL196866 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL560724 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL9686185 | 0.97 | TSHR (0.59) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL988734 | 0.97 | TSHR (0.59) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL197255 | 0.97 | — | — | |
| SCHEMBL3284317 | 0.94 | TSHR (0.56) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL6859053 | 0.92 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL10035947 | 0.90 | MEN1 (0.60) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109264-A1 | FILM, METHOD FOR MANUFACTURING SAME, AND IMAGE DISPLAY DEVICE | KANEKA CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| WO-2024176902-A1 | POWER-STORAGE-DEVICE AQUEOUS BINDER SOLUTION, POWER-STORAGE-DEVICE SLURRY, POWER-STORAGE-DEVICE ELECTRODE, POWER-STORAGE-DEVICE SEPARATOR, POWER-STORAGE-DEVICE SEPARATOR/ELECTRODE STACK, AND POWER STORAGE DEVICE | 荒川化学工業株式会社 | 2024-08-29 | — | — | WO | disclosed |
| WO-2023149435-A1 | RESIN COMPOSITION, MOLDED OBJECT, AND FILM | 株式会社カネカ | 2023-08-10 | — | — | WO | disclosed |
| WO-2023100806-A1 | FILM, PRODUCTION METHOD THEREFOR, AND IMAGE DISPLAY DEVICE | 株式会社カネカ | 2023-06-08 | — | — | WO | disclosed |
| WO-2023085325-A1 | RESIN COMPOSITION, MOLDED BODY AND FILM | 株式会社カネカ | 2023-05-19 | — | — | WO | disclosed |
| WO-2022224933-A1 | LAMINATED SUBSTRATE, LAMINATE, METHOD FOR PRODUCING LAMINATE, LAMINATE EQUIPPED WITH MEMBER FOR ELECTRONIC DEVICE, AND METHOD FOR PRODUCING ELECTRONIC DEVICE | ＡＧＣ株式会社 | 2022-10-27 | — | — | WO | disclosed |
| WO-2022176919-A1 | POLYIMIDE FILM AND PRODUCTION METHOD THEREFOR, HARDCOAT FILM, AND IMAGE DISPLAY DEVICE | 株式会社カネカ | 2022-08-25 | — | — | WO | disclosed |
| US-11198280-B2 | Medical film and method for producing same, medical coating composition, medical device and method for producing same | MITSUI CHEMICALS, INC. (JP) | 2021-12-14 | — | — | US | disclosed |
| US-20210101862-A1 | DIAMINE COMPOUND, METHOD OF PREPARING DIAMINE COMPOUND, AND POLYIMIDE | ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) | 2021-04-08 | — | — | US | disclosed |
| EP-3663278-A1 | DIAMINE COMPOUND, PRODUCTION METHOD FOR DIAMINE COMPOUND, AND POLYIMIDE | Arakawa Chemical Industries, Ltd. (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-6531568-B1 | Melt processable thermoplastic resins formed from chemical intermediates such as polyamic acids having chemical, heat, oxidation and radiation resistance | MITSUI CHEMICALS, INC. (JP) | 2003-03-11 | — | — | US | disclosed |
| US-20020182536-A1 | Polyimides and polyamic acids | MITSUI CHEMICALS, INC. (JP) | 2002-12-05 | — | — | US | disclosed |
| EP-1225192-A1 | POLYIMIDES AND POLYAMIC ACIDS | Mitsui Chemicals, Inc. (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-1148078-A1 | POLYIMIDE CONTAINING CROSSLINKABLE GROUP AND PROCESS FOR PRODUCING THE SAME | Mitsui Chemicals, Inc. (JP) | 2001-10-24 | — | — | EP | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0833879-A1 | VAPOR PHASE COMBUSTION METHOD AND COMPOSITIONS II | ORR, William C. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0763079-A1 | VAPOR PHASE COMBUSTION METHODS AND COMPOSITIONS | ORR, William C. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1996040844-A1 | VAPOR PHASE COMBUSTION METHOD AND COMPOSITIONS II | ORR WILLIAM C (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1995033022-A1 | VAPOR PHASE COMBUSTION METHODS AND COMPOSITIONS | ORR WILLIAM C (US) | 1995-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210101862-A1 | DIAMINE COMPOUND, METHOD OF PREPARING DIAMINE COMPOUND, AND POLYIMIDE | PARP2, RFC2, PARP12 | MEN1 1943/4885KMT2A 157/4885TSHR 2270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.